These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2635325)

  • 21. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations.
    Davies RF; Dubé LM; Mousseau N; McGilveray I; Beanlands DS
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):634-41. PubMed ID: 3172810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free fatty acids and the binding of sulfonamides in the serum of genetically obese Zucker rat.
    Kaul S; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):317-20. PubMed ID: 3613761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability.
    Kurono M; Fujii A; Murata M; Fujitani B; Negoro T
    Biochem Pharmacol; 2006 Jan; 71(3):338-53. PubMed ID: 16324683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular aspects of ligand binding to serum albumin.
    Kragh-Hansen U
    Pharmacol Rev; 1981 Mar; 33(1):17-53. PubMed ID: 7027277
    [No Abstract]   [Full Text] [Related]  

  • 25. Bilirubin-albumin binding and a possible mechanism of kernicterus.
    Lee JJ; Cowger ML
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):327-39. PubMed ID: 4859223
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty acid binding sites of human and bovine albumins: differences observed by spin probe ESR.
    Muravsky V; Gurachevskaya T; Berezenko S; Schnurr K; Gurachevsky A
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Sep; 74(1):42-7. PubMed ID: 19540798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of the bromsulphtalein method in investigations of the binding of substances to albumin.
    Kucerová L; Hoenig V
    Acta Univ Carol Med (Praha); 1970; 16(3):235-60. PubMed ID: 5491528
    [No Abstract]   [Full Text] [Related]  

  • 29. Optical studies of drug-protein complexes. 3. Interaction of flufenamic acid and other N-arylanthranilates with serum albumin.
    Chignell CF
    Mol Pharmacol; 1969 Sep; 5(5):455-62. PubMed ID: 5823761
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of uremic toxins and nonesterified fatty acids on drug and thyroid hormone binding in serum.
    Lim CF; Stockigt JR
    Clin Chem; 1998 Nov; 44(11):2380-1. PubMed ID: 9799777
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of albumin and non-esterified fatty acids on serum prostacyclin binding in pregnancy.
    O'Brien WF; Saba HI; Knuppel RA; Benoit R; Bruce A
    Prostaglandins; 1989 Jan; 37(1):61-7. PubMed ID: 2655012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition of bismuth in the rat. I. Red blood cell and plasma protein binding.
    Rao N; Feldman S
    Pharm Res; 1990 Feb; 7(2):188-91. PubMed ID: 2308899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma.
    Nilsen OG; Storstein L; Jacobsen S
    Biochem Pharmacol; 1977 Feb; 26(3):229-35. PubMed ID: 843392
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma protein binding of fentanyl.
    Bower S
    J Pharm Pharmacol; 1981 Aug; 33(8):507-14. PubMed ID: 6115925
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug binding kinetics in patients with diabetes mellitus.
    Wörner W; Preissner A; Kratzer W; Keita Y; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):489-90. PubMed ID: 1490799
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions of sulfonylureas with plasma proteins.
    Hsu PL; Ma JK; Luzzi LA
    J Pharm Sci; 1974 Apr; 63(4):570-3. PubMed ID: 4208196
    [No Abstract]   [Full Text] [Related]  

  • 37. Quantitative and qualitative aspects of the plasma protein binding of carbenoxolone, an ulcer-healing drug.
    Parke DV; Lindup WE
    Ann N Y Acad Sci; 1973 Nov; 226():200-13. PubMed ID: 4203419
    [No Abstract]   [Full Text] [Related]  

  • 38. The binding of digoxin by the serum proteins.
    Evered DC
    Eur J Pharmacol; 1972 May; 18(2):236-44. PubMed ID: 5037383
    [No Abstract]   [Full Text] [Related]  

  • 39. Thin-layer chromatographic determination of 3H-labelled stobadin in rat plasma for pharmacokinetic purposes.
    Bittererová J; Soltés L; Kállay Z; Trnovec T
    Pharmazie; 1990 Jun; 45(6):437-8. PubMed ID: 2402532
    [No Abstract]   [Full Text] [Related]  

  • 40. Aspects of multiple binding of anticoagulants and other drugs.
    Wosilait WD
    Gen Pharmacol; 1977; 8(1):7-12. PubMed ID: 590727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.